Vertebroplasty in patients with multiple myeloma with vertebral compression fractures: protocol for a single-blind randomised controlled trial.
Line Adsboell Wickstroem, Leah Carreon, Thomas Lund...
https://pubmed.ncbi.nlm.nih.gov/34489267/Actively Recruiting
Led by Spine Centre of Southern Denmark · Updated on 2024-12-03
90
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are investigating the role of vertebroplasty in addition to regular medical treatment for patients with multiple myeloma who have newly diagnosed or known vertebral lesions. This trial aims to compare outcomes between patients receiving standard care alone and those receiving vertebroplasty plus standard care to better understand the effectiveness of surgical intervention in these patients. The study is a randomized controlled trial involving patients with spinal fractures due to multiple myeloma and relevant pain. Participants are randomly assigned to either receive vertebroplasty, which involves injecting cement into the vertebral lesions, alongside regular medical treatment, or to receive regular medical treatment alone. Patients are stratified based on factors such as the number of vertebral levels planned for vertebroplasty and previous vertebral fractures not treated with vertebroplasty. Those in the vertebroplasty group will have the procedure performed at specialized facilities, followed by standard outpatient clinical follow-up including spine X-rays 12 weeks after surgery. During the study, patients will be closely monitored with weekly contacts by a research nurse for the first 12 weeks and additional follow-ups at 3 and 12 months. Assessments include questionnaires on disability, pain levels, quality of life, and long-term vertebral stability. The primary outcome measured is improvement in back-specific disability four weeks after treatment initiation, with several secondary outcomes tracked up to 12 months. The total participation period ensures careful evaluation of both short- and long-term effects of the treatments.
CONDITIONS
Examination of Vertebroplasty in Addition to Regular Treatment of Patients With Multiple Myeloma.
L
Line Wickstroem, MD
M
Mikkel Andersen, Professor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Spine Centre of Southern Denmark
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Participants are evaluated by their hematologist and surgical team to determine eligibility and receive information about the study.
Duration - Up to 12 months post-initiation of treatment
Participants are randomized to either vertebroplasty plus regular medical treatment or regular medical treatment alone.
Weekly contacts with a research nurse for the first 12 weeks, then visits at 3 and 12 months; participants receiving vertebroplasty have a scheduled outpatient visit with the surgeon at 12 weeks post-operation.
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Line Adsboell Wickstroem, Leah Carreon, Thomas Lund...
https://pubmed.ncbi.nlm.nih.gov/34489267/Spine Centre of Southern Denmark
Lead Sponsor